Risperdal Litigation: Risk Management Advice for Psychiatrists
If you’ve paid attention to the news lately, you’ve more than likely seen headlines about Johnson & Johnson being involved in litigation related to the marketing of Risperdal. Recently, our clients have begun to receive more requests for medical records in connection with Risperdal litigation.
In the event that you receive any such request, we would like to remind you to keep the following risk management advice in mind:
1) Send your records request in for review. Your risk managers are ready and willing to assist you in any way possible.
2) As with any safety information related to medications you prescribe, you should review the appropriateness of continuing those medications. Remember to discuss the appropriateness of continuing such medications with your patient and/or his guardian(s) in order to obtain updated informed consent.
3) Never alter the record! If you believe an entry needs to be amended call us before doing so.
Clients of The Psychiatrists’ Program are encouraged to call the Risk Management Consultation Service at (800) 527-9181.